Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in premenopausal women.
Peptigrity tracks PT-141 across 219 shops with 114 independent lab tests and an average HPLC purity of 98.82%.
Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in premenopausal women.
Every submitted test helps the community verify purity across brands. Free, fast, independent.